Skip to main content
Fig. 3 | BMC Medical Imaging

Fig. 3

From: The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ

Fig. 3

Imaging features of invasive ductal carcinoma on final surgical pathology. Axial fat-suppressed T1-weighted contrast-enhanced MRI showed a segmental distributed non-mass enhancement with clustered ring enhancement (left). MRI with a CAD color overlay map indicated the tumor size and enhancement kinetics, i.e., a 270% peak enhancement and a 3% washout component (right)

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us